Amidino-containing Schiff base copper(II) and iron(III) chelates as a thrombin inhibitor.
Four series of Schiff base copper(II) and iron(III) chelates were synthesized from 4-formyl-3-hydroxybenzamidine or 3-formyl-4-hydroxybenzamidine and various L- or D-amino acids. Their inhibitory activities for bovine alpha-thrombin (abbreviated as thrombin) were determined. The most potent thrombin inhibitor in this series is copper(II) chelate (1g') derived from 4-formyl-3-hydroxybenzamidine and D-Trp. Its Ki value, 2.7x10(-8) M, is comparable to that of Argatroban (MD-805), which is a clinically used compound. The iron(III) chelates derived from 4-formyl-3-hydroxybenzamidine and hydrophobic L-amino acids (Val, Ile, Leu, Phe, Trp, Met) also exhibited higher inhibitory potency. It appears that coordination geometry composed of metal ion, amidino group, amino acid side chain is well accommodated to the thrombin active site. From the Ki values of Schiff base metal chelates for thrombin, the structure-activity relationships between the chelates and active site of thrombin were discussed.
Toyota
Eiko
E
Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Hokkaido, Japan.
Sekizaki
Haruo
H
Takahashi
Yu-u
YU
Itoh
Kunihiko
K
Tanizawa
Kazutaka
K
D002614:Chelating Agents / Q000737:chemistry / Q000494:pharmacology*; D003300:Copper / Q000378:metabolism*; D007501:Iron / Q000378:metabolism*; D012545:Schiff Bases / Q000378:metabolism; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000378:metabolism
D002614:Chelating Agents; D012545:Schiff Bases; D003300:Copper; D007501:Iron; D013917:Thrombin